Altogether, we demonstrated that pharmacological inhibition of CDK8/19 promotes apoptosis in CML cells treated with BCR-ABLi by attenuating BCR-ABLi-induced cell cycle arrest thereby preventing the escape from apoptosis (Fig. 6D). This evidence concerns the gene CDK8 and chronic myelogenous leukemia, BCR-ABL1 positive.